Kristi Norris, Ph.D.

Affiliations: 
2008 Biochemistry and Molecular Genetics The George Washington University, Washington, DC, United States 
Area:
Cell Biology, Virology Biology
Google:
"Kristi Norris"
Mean distance: (not calculated yet)
 

Parents

Sign in to add mentor
Richard J Youle grad student George Washinton University
Richard J. Youle grad student 2008 The George Washington University
 (Cellular effects of vMIA highlight shared machinery of apoptosis regulation and mitochondrial morphogenesis.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Norris KL, Hao R, Chen LF, et al. (2015) Convergence of Parkin, PINK1, and α-Synuclein on Stress-induced Mitochondrial Morphological Remodeling. The Journal of Biological Chemistry. 290: 13862-74
Ma J, Edlich F, Bermejo GA, et al. (2012) Structural mechanism of Bax inhibition by cytomegalovirus protein vMIA. Proceedings of the National Academy of Sciences of the United States of America. 109: 20901-6
Norris KL, Yao TP. (2012) Lysine modifications and autophagy. Essays in Biochemistry. 52: 65-77
Cleland MM, Norris KL, Karbowski M, et al. (2011) Bcl-2 family interaction with the mitochondrial morphogenesis machinery. Cell Death and Differentiation. 18: 235-47
Suen DF, Norris KL, Youle RJ. (2008) Mitochondrial dynamics and apoptosis. Genes & Development. 22: 1577-90
Norris KL, Youle RJ. (2008) Cytomegalovirus proteins vMIA and m38.5 link mitochondrial morphogenesis to Bcl-2 family proteins. Journal of Virology. 82: 6232-43
Holman DH, Turner LS, El-Zawahry A, et al. (2008) Lysosomotropic acid ceramidase inhibitor induces apoptosis in prostate cancer cells. Cancer Chemotherapy and Pharmacology. 61: 231-42
Karbowski M, Norris KL, Cleland MM, et al. (2006) Role of Bax and Bak in mitochondrial morphogenesis. Nature. 443: 658-62
Norris JS, Norris KL, Holman DH, et al. (2005) The present and future for gene and viral therapy of directly accessible prostate and squamous cell cancers of the head and neck. Future Oncology (London, England). 1: 115-23
See more...